SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News

Vorsprung durch TechnoPharm: Pharma tech firms head to Nuremberg

29-Sep-2014 - in-Pharmatechnologist.com is live from Nuremberg to bring you the best from TechnoPharm and POWTECH 2014, Europe's largest processing and powder shows.

Partnership looks to expand UK drug manufacturing

25-Sep-2014 - The Medicines Manufacturing Industry Partnership (MMIP) between the ABPI (Association of the British Pharmaceutical Industry), BIA (BioIndustry Association) and a number of companies aims to make the UK a more attractive destination for pharma manufacturing. 

CORRECTION

Boehringer cutting German workforce by 600 but production jobs safe for now

24-Sep-2014 - Hundreds of workers brought in to help fix manufacturing issues at a Boehringer Ingelheim facility will not be affected despite the firm looking to shave 600 jobs in a €450m ($580m) cost-cutting initiative.

Generic Sovaldi makers could pocket upwards of $600m says analyst

24-Sep-2014 - The market opportunity for each Indian drugmakers granted a license to manufacture Gilead’s hepatitis C drug Sovaldi could be worth over $600m, an analyst has calculated.

Novartis cuts 83 more jobs at closing NY Diovan plant

23-Sep-2014 - Novartis has announced a second round of lay-offs at its manufacturing site in Suffern, New York ahead of the plant’s closure in 2016.

Pfizer and Irish port authorities working to stop API plant gathering dust

22-Sep-2014 - Pfizer is working with Irish authorities to avoid a repeat of a 2013 incident when dust produced from Cork harbour entered its nearby API facility.

News in brief

Merck Serono teams with Lupin to bring drugs to emerging markets

17-Sep-2014 - Merck Serono has struck a deal with Indian drugmaker Lupin to bring a number of drugs for cardiovascular and diabetes diseases to emerging markets.

Hospira bucks Australian generics downturn with $14m investment

17-Sep-2014 - Hospira has invested 15m AUD ($14m) in a Victoria injectables plant it says will continue to make drugs for export despite the economic downturn and strong Australian dollar.

Indian drugmakers to bring cheap HCV drug Sovaldi to developing world

16-Sep-2014 - Gilead has granted seven Indian drugmakers licenses to produce generic versions of its $1,000 a pill drug Sovaldi to increase access to hepatitis C medicines in 91 developing countries.

Industry groups take issue with FDA draft guidance on outsourcing facilities

11-Sep-2014 - Industry groups BIO (Biotechnology Industry Association) and GPhA (Generic Pharmaceutical Association) are calling for outsourcing facilities to be held to the same standards as other, larger manufacturers.

Molecular Profiles buys tech for liquid capsule manufacture

10-Sep-2014 - Molecular Profiles has expanded its capsule-filling services from solids to liquids with investment in equipment at its UK site.

News in brief

Roche cuts 100 Spanish jobs in downsizing drive

03-Sep-2014 - Roche has revealed plans to cut 100 jobs from its business in Spain “due to restructuring efforts to improve business efficiency.”

Novo Nordisk snaps up Olympus plant and rehires laid off NH workers

29-Aug-2014 - Novo Nordisk has bought a biomanufacturing facility earmarked for closure by Olympus Biotech and begun rehiring staff in order to support its haemophilia product pipeline.

INFOGRAPHIC

Is Pfizer now eyeing up Actavis three months after failed AZ bid?

28-Aug-2014 - Pfizer is rumoured to be eyeing up Actavis three months after failing to woo AstraZeneca in a $120bn megamerger, but what would such a deal bring to the Pharma Giant? In-Pharmatechnologist investigates.

Correction

GE Healthcare: plans to move New Jersey ops to new Massachusetts HQ

22-Aug-2014 - GE Healthcare has said it plans to relocate operations in New Jersey to its new Massachusetts life sciences headquarters.

Ben Venue site has no place in injectables network, says new owner Hikma

21-Aug-2014 - Ben Venue Laboratories will remain inactive says new owner Hikma as it looks to optimise its injectables manufacturing network.

Novartis invests $35m in stem cell tech company with option to acquire

20-Aug-2014 - Novartis has invested $35m (€26.3m) for a 15% stake in Israel-based Gamida Cell, which offers stem cell expansion technologies and therapeutics.

G-CON launches transmissible disease containment POD

18-Aug-2014 - Access to portable and flexible technology could be one way of containing transmissible diseases says G-CON as it launches a more readily deployable version of its ‘POD’ manufacturing suite.

SCM's woes part of UK-wide aseptic slowdown, says ex-owner

14-Aug-2014 - GMP failures at an aseptic plant owned by SCM Pharma are part of a wider industry trend affecting several sterile sites in the UK, according to the ex-owner of the CDMO.

Boehringer Ingelheim aims to cut German costs 15% as revenues drop

13-Aug-2014 - German jobs are safe despite a programme that will cut the cost of operations by 15%, Boehringer Ingelheim says as it reacts to international price reductions.

Merck Millipore invests €12m in French facility

13-Aug-2014 - Merck Millipore, the life science division of Merck KGaA, will invest €12m ($16m) at its Molsheim, France facility to expand its ready-to-use media manufacturing capabilities and capacity.

Hep C biocatalyst sales slump as Codexis feels Sovaldi impact

07-Aug-2014 - Codexis has felt the impact of Gilead’s Sovaldi with product revenues tumbling almost 60% due to the reduction in its hepatitis C biocatalyst and intermediate business.

Fresenius: US supply from troubled Indian plant to restart in Q3

05-Aug-2014 - Fresenius Kabi has recommenced production at a troubled Indian facility and expects to start shipping APIs to the US in the next few weeks.

Amgen to slash 23% of its manufacturing footprint and 2,900 US jobs

30-Jul-2014 - Amgen is slashing 15% of its workforce and closing two US manufacturing facilities as part of a restructure the firm says will save $700m (€520m) a year.

Biocon: Political turmoil hits sales, but quality systems ensure future

29-Jul-2014 - Robust quality systems differentiate Biocon from other Indian manufacturers, the firm says, despite political turmoil in the Middle East and North Africa impacting first quarter 2015 sales.

Spotlight

Galen plans to sell “green whistle” pain drug in UK and Ireland

Galen plans to sell “green whistle” inhalable pain drug in UK and Ireland

Almac’s subsidiary Galen has licensed UK sales and marketing rights to an emergency pain drug nicknamed the...

Trial transparency: NICE stands firm on data

Trial transparency: NICE stands firm on data

The UK’s NICE says it will go over drug companies’ heads and get clinical trial data from...

Mannkind looks to Sanofi for secondary supply of inhalable insulin API

Mannkind looks to Sanofi for secondary supply of inhalable insulin API

Mannkind says Sanofi could become a second API supplier for its recently approved inhalable insulin drug Afrezza...

Drug prices will continue to vary accross Africa says analyst

Drug prices will continue to vary accross Africa says analyst

High importation costs and country-to-country differences in national healthcare systems mean drugmakers will continue to vary the...

Hyperion ends drug candidate truials after discovering fake data

$20m Andromeda strains Hyperion as fake data ends diabetes drug development

Hyperion says it is “shocked and disheartened” after discovering Phase III trial data for a type 1...

ISPE offers preview to drug shortages prevention plan

ISPE offers preview to drug shortages prevention plan

The International Society for Pharmaceutical Engineering (ISPE) last week offered up a preview to its plan to...

Key Industry Events

 

Access all events listing

Our events, Events from partners...